• TCF25-Directed Lysosomal Acidification During Glucose Starva

  2026-04-30

  Ren et al. (2025) identify TCF25 as a nutrient sensor that coordinates cellular metabolic adaptation and cell death under glucose starvation by enhancing lysosomal acidification via V-ATPase. This study uncovers a mechanistic link between ferritinophagy, lysosome-dependent cell death, and metabolic stress, offering new avenues for research in metabolic and ischemic disorders.

• Oligo (dT) 25 Beads: Driving Eukaryotic mRNA Isolation Preci

  2026-04-30

  Oligo (dT) 25 Beads leverage superparamagnetic technology for rapid, high-yield eukaryotic mRNA isolation, streamlining workflows from single-cell RNA-seq to RT-PCR. Discover protocol enhancements, troubleshooting strategies, and translational insights inspired by recent Alzheimer’s immunology research.

• Rotigotine: Dopamine D2/D3 Receptor Agonist for PD Research

  2026-04-29

  Rotigotine’s high-affinity D2/D3 receptor agonism enables robust modeling of Parkinson’s disease motor and non-motor symptoms, including overactive bladder. APExBIO’s validated formulation supports reproducible in vitro and in vivo workflows, empowering advanced dopaminergic signaling studies and neuroprotection assays.

• Guanabenz Acetate: α2-Adrenergic Receptor Agonist for GPCR R

  2026-04-29

  Guanabenz Acetate is a selective α2-adrenergic receptor agonist with high purity, precise subtype selectivity, and robust solubility in DMSO, making it a preferred tool for GPCR signaling and neuroscience receptor research. Its use is supported by peer-reviewed evidence and standardized vendor quality control, but it is not intended for diagnostic or therapeutic use.

• WM-8014: Unlocking Epigenetic Targets for Senescence-Based C

  2026-04-28

  This thought-leadership piece examines WM-8014, a next-generation selective KAT6A inhibitor, through the lens of mechanistic insight and translational opportunity. Drawing on new evidence from time-gated CRISPR screens and integrating best practices from advanced cell cycle arrest and oncogene-induced senescence assays, we outline actionable strategies for cancer biology researchers aiming to translate epigenetic drug targets into future therapies. The article uniquely bridges bench-to-bedside imperatives, highlights the clinical promise and practical limitations, and positions WM-8014 as essential for those pioneering the next wave of targeted, non-cytotoxic cancer interventions.

• D-Luciferin Sodium Salt: Optimizing Firefly Luciferase Assay

  2026-04-28

  D-Luciferin sodium salt enables precise, ATP-dependent bioluminescence workflows—delivering sensitive, quantitative monitoring in advanced cell and immunotherapy research. Recent breakthroughs in CAR macrophage programming underscore its pivotal role in non-invasive imaging and metabolic profiling.

• Cycloheximide (SKU A8244): Bench-Validated Protein Synthesis

  2026-04-27

  This scenario-driven article guides biomedical researchers and lab technicians through core challenges in apoptosis, protein turnover, and translational control assays, demonstrating how Cycloheximide (SKU A8244) from APExBIO delivers reproducible, data-backed solutions. Evidence-based Q&A blocks address experimental pitfalls, protocol optimization, and vendor selection, ensuring readers gain actionable insights for robust cell-based workflows.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-27

  Wang et al. identify a METTL16-SENP3-LTF signaling pathway as a key regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic insights reveal translational opportunities for targeting iron metabolism and cell death pathways in HCC therapy.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-04-26

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe addresses the need for high-contrast, lipophilic fluorescent labeling of plasma membranes in both live and fixed biological samples. It is best applied in neuronal tracing, cell migration, and membrane dynamics workflows where organic solvent-based protocols are suitable. This probe is not recommended for water-based staining or exclusive organelle targeting.

• Perineuronal Net Degradation Impairs Social Memory in AD Mod

  2026-04-25

  This study demonstrates that loss of perineuronal nets (PNNs) in the hippocampal CA2 region underlies social cognition deficits in Alzheimer’s disease (AD) mouse models. By linking PNN disruption to upregulated matrix metalloproteinase (MMP) activity and showing that MMP inhibition preserves social memory, the research establishes extracellular matrix integrity as a critical factor in neurodegeneration.

• Deferasirox: Oral Iron Chelator Workflows for Cancer Researc

  2026-04-24

  Deferasirox, a clinically validated oral iron chelator, is revolutionizing both iron overload management and experimental oncology by targeting iron metabolism and ferroptosis resistance. This article delivers actionable protocols, troubleshooting strategies, and translational insights to maximize reproducibility and impact in cancer and hematology research.

• HotStart 2X Green qPCR Master Mix: Precision for Gene Expres

  2026-04-24

  Unlock exceptional specificity and reproducibility in real-time PCR gene expression analysis with HotStart™ 2X Green qPCR Master Mix. Explore advanced, evidence-backed workflows, application-driven troubleshooting, and practical insights that translate the latest immune evasion research into actionable assay design advantages.

• Harnessing PPM-18 for NF-κB Pathway Inhibition in Sepsis Res

  2026-04-23

  PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) stands out as a next-generation iNOS expression inhibitor, enabling precise control over NF-κB signaling in inflammation and sepsis models. This article delivers actionable workflows, troubleshooting insights, and translational tips to maximize reproducibility and scientific rigor with APExBIO's trusted compound.

• COX-2 Pathway’s Role in Muscle Ischemia and Revascularizatio

  2026-04-23

  This study investigates how the cyclooxygenase-2 (COX-2) pathway modulates tissue ischemia and revascularization after skeletal muscle injury induced by Bothrops asper venom. Using lumiracoxib, a selective COX-2 inhibitor, the authors reveal that early inhibition of COX-2 aggravates ischemia but enhances late-stage angiogenic signaling and microvascular remodeling, refining our understanding of COX-2’s dual role in muscle regeneration.

• Discovery of 14-3-3 Interactors ATG9A, PTOV1 in Cancer Mecha

  2026-04-22

  This study identifies ATG9A and PTOV1 as novel 14-3-3 binding proteins, uncovering their regulatory roles in autophagy and oncogenic signaling. The findings provide mechanistic insight into basal autophagy and PTOV1 stability, with implications for cancer biology and potential therapeutic targeting.

16189 records 1/1080 page Next 12345 下5页 Last page